Marion Elizabeth Reid (born 1943 or 1944)[1] is a British scientist specialising in immunohematology and author based in Bristol. She has worked in both the United Kingdom and the United States.[2]
Early life and education
Reid was born in Winchester, England. At age 10, she was told she was "incapable of being
taught" and "would have a hard time holding a job".[3]
Reid directed the Laboratory of Immunohematology at the New York Blood Center, where she led the transition from serologic methods for characterizing red cell antigens and antibodies to a combination of serology and DNA-based genotyping of blood group antigens.[5]
She published hundreds of articles and was described by reviewers as a "scientist and
world-renowned immunohematologist".[6] Her laboratory identified novel blood group antigens and alleles in several different ethnic groups.[7][8][9][10] She holds a patent for a DNA-based method to identify compatible donors for patients requiring blood transfusions.[11]
^ ab"Meet our Board". National Centre for Integrative Medicine. Retrieved 8 October 2024.
^ abReid, M. E. (15 August 2006). "International Woman in Transfusion Award lecture: selected lessons learnt from blood groups". ISBT Science Series. 1 (1). Wiley: 112–119. doi:10.1111/j.1751-2824.2006.00047.x. ISSN1751-2816.
^Shirey, R. Sue; King, Karen E. (2012). "The Discovery and Significance of Blood Groups by Marion Reid and Ian Shine. Cambridge, MA: SBB Books, 2012. 192 pages. ISBN: 978-1-59572-422-9". Transfusion. 52 (11). Wiley: 2487. doi:10.1111/j.1537-2995.2012.03920.x. ISSN0041-1132.
^Moulds JM, Persa R, Rierson D, Billingsley KL, Noumsi GT, Hue-Roye K, Reid ME (November 2013). "Three novel alleles in the Kell blood group system resulting in the Knull phenotype and the first in a Native American". Transfusion. 53 (11 Suppl 2): 2867–71. doi:10.1111/trf.12205. PMID23581548.
^Reid ME, Hue-Roye K, Velliquette RW, Larimore K, Moscarelli S, Ohswaldt N, Lomas-Francis C (2013). "SC*994C>T causes the Sc(null) phenotype in Pacific Islanders and successful transfusion of Sc3+ blood to a patient with anti-Sc3". Immunohematology. 29 (2): 69–72. doi:10.21307/immunohematology-2019-127. PMID24094239.
^Westhoff CM, Vege S, Nickle P, Singh S, Hue-Roye K, Lomas-Francis C, Reid ME (October 2011). "Nucleotide deletion in RHCE*cE (907delC) is responsible for a D- - haplotype in Hispanics". Transfusion. 51 (10): 2142–7. doi:10.1111/j.1537-2995.2011.03144.x. PMID21517889.
^Reviews of The Discovery and Significance of the Blood Groups:
Shirey, R. Sue; King, Karen E. (2012). "The Discovery and Significance of Blood Groups by MarionReid and IanShine. Cambridge, MA: SBB Books, 2012. 192 pages. ISBN: 978-1-59572-422-9". Transfusion. 52 (11). Wiley: 2487. doi:10.1111/j.1537-2995.2012.03920.x. ISSN0041-1132.
^Reid ME (September 2013). "Emily Cooley lecture 2012: Emily Cooley and techniques that have been applied to characterize DO and JR blood groups". Transfusion. 53 (9): 1876–83. doi:10.1111/trf.12207. PMID23581612.